Full-Time

Corporate Accountant

Confirmed live in the last 24 hours

Neuralink

Neuralink

501-1,000 employees

Develops brain-computer interfaces for medical use

Compensation Overview

$85k - $159k/yr

Mid, Senior

Austin, TX, USA

Category
Financial Accounting
Tax Accounting
Financial Planning
Accounting
Requirements
  • 4+ years experience with a mix of public accounting and industry experience
  • Bachelor's degree or above in accounting, finance, or related field
  • CPA designation or equivalent
Responsibilities
  • Performing daily bookkeeping to ensure the timeliness, completeness, and accuracy of the Company’s accounting records
  • Executing month-end financial statements close procedures, with a focus on key areas of capital assets, operating and finance leases, accrued liabilities, accounts payable, payroll expense and liabilities, bank and credit card account reconciliations, and stock-based compensation expenses
  • Preparing monthly journal entries and reconciliation workbooks to support month-end balances reported
  • Identifying and correcting errors where necessary, and providing timely feedback to support other team members’ growth
  • Preparing quarterly financial statements to ensure compliance with 701 disclosure requirements
  • Developing weekly cash flow forecasts, analyzing budgeting-versus-actual variances, and preparing other financial forecasts
  • Preparing and filing tax information forms including 3921, 1099-B, and assisting with the review of W-2 forms
  • Leading in researching, developing, maintaining, and documenting corporate accounting policies and procedures in line with U.S. GAAP or other relevant regulatory guidance
  • Assisting in the design, development, and implementation of internal control procedures in accordance with the Internal Control over Financial Reporting (ICFR)
  • Evaluating and assisting with the implementation of new accounting and procurement software
  • Collaborating with cross-functional teams to automate routine procedures, design and enhance processes, and strengthen internal controls
  • Assisting team members with equity administration and other ad hoc projects
Desired Qualifications
  • Public accounting experience
  • Industry experience or audit engagement experience in biotechnology, medical devices, or other technology companies
  • Experience with NetSuite, Quickbooks, Shareworks, Adaptive, or ZipHQ
  • Intermediate Excel skills

Neuralink develops brain-computer interfaces (BCIs) that enable direct communication between the brain and external devices. Their main product, the N1 Implant, is a small, fully implantable device that allows users to control computers or mobile devices through their brain activity. The implant is powered by a wirelessly charged battery and uses custom chips to process neural signals, which are then sent to the Neuralink Application that translates these signals into commands. What sets Neuralink apart from competitors is its use of a surgical robot that precisely inserts ultra-thin threads into the brain, minimizing damage during the procedure. The company's goal is to restore autonomy to individuals with mobility issues or neurological disorders, while also appealing to those interested in enhancing cognitive abilities.

Company Size

501-1,000

Company Stage

Series E

Total Funding

$1.3B

Headquarters

Fremont, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Neuralink raised $650 million in Series E funding to expand patient access.
  • The FDA granted 'breakthrough' status for Neuralink's speech restoration device.
  • Advancements in AI-driven neural signal decoding enhance Neuralink's device performance.

What critics are saying

  • Ethical concerns about brain-machine interfaces could lead to public backlash.
  • Competing technologies from companies like Synchron and Kernel may outpace Neuralink.
  • The complexity and cost of N1 Implant surgeries may limit accessibility.

What makes Neuralink unique

  • Neuralink's N1 Implant is a fully implantable, cosmetically invisible brain-machine interface.
  • The surgical robot developed by Neuralink ensures precise and minimally invasive implantation.
  • Neuralink's technology translates brain activity into computer commands, restoring autonomy to users.

Help us improve and share your feedback! Did you find this helpful?

Benefits

An opportunity to change the world and work with some of the smartest and the most talented experts from different fields.

Growth potential. We rapidly advance team members who have an outsized impact.

Excellent medical, dental, and vision insurance through a PPO plan; parental leave.

Flexible time off + paid holidays.

Equity + 401(k) plan.

Commuter Benefits.

Meals provided.

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

0%
Tech Gist Africa
Jun 15th, 2025
Neuralink Raises $650M for Brain Implants

Neuralink, Elon Musk's neurotechnology company, raised $650 million in a Series E funding round. The funds will expand patient access, develop new brain implant devices, and enhance clinical trials. Neuralink's technology, tested in patients with severe paralysis, allows control of devices via thoughts. The FDA granted "breakthrough" status for its speech restoration device. Investors include ARK Invest, Sequoia Capital, and others. Neuralink's pre-funding valuation was approximately $9 billion.

Breaking The News
Jun 12th, 2025
Neuralink raises $649M in equity financing

Neuralink Corp., led by CEO Jared Birchall, has raised $649 million in an equity sale, as revealed in an SEC filing. The sale took place on May 30, 2025, with a minimum investment of $12,019 required from outside investors. The company did not disclose its revenue range.

CNBC
Jun 3rd, 2025
5 things to know before the stock market opens Tuesday

Neuralink, Elon Musk's brain tech startup, said it has closed a $650 million funding round led by ARK Invest, Founders Fund, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners and others.

Goo News
Jun 3rd, 2025
Neuralink Raises $650M in Funding Round

Neuralink, led by Elon Musk, raised $650 million in a Series E funding round, with participation from at least 11 investment firms, including Ark Investment Management and Sequoia Capital. The company plans to use the funds to expand patient access and develop next-generation devices that enhance the connection between biological intelligence and AI. Neuralink is valued at $9 billion. Since the last funding round in August 2023, five patients with severe paralysis have used its devices.

ITmedia
Jun 2nd, 2025
Neuralink Raises $650M in Series E

Neuralink, founded by Elon Musk in 2016, announced on June 2 that it raised $650 million in a Series E funding round. Investors included ARK Invest, Founders Fund, Sequoia Capital, and Thrive Capital. The company is conducting clinical trials, including implanting brain chips in five severely paralyzed patients, and has started trials at major neurosurgical institutions. The funding will expand clinical trials and accelerate innovation in future devices connecting biology and AI.